Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKAG1 | P54619 | 1/20 | 0.36 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.36 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.36 |
| ▸ | SLC9A3 | P48764 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 5/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 2/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.31 |
| ▸ | HTR7 | P34969 | 2/20 | 0.30 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3141267 | 0.75 | RXFP1 (0.41) | MGLLKDM4E | |
| SCHEMBL4881017 | 0.68 | MEN1 (0.38) | SLC6A2SLC6A4SLC6A3KDM1A | |
| SCHEMBL7823337 | 0.68 | KEAP1 (0.42) | SLC9A3KDM4EHTR7 | |
| SCHEMBL7814732 | 0.68 | KEAP1 (0.46) | SLC9A3 | |
| SCHEMBL29557633 | 0.67 | KEAP1 (0.44) | KDM4ENOTUM | |
| SCHEMBL138181 | 0.67 | KEAP1 (0.44) | KDM4ENOTUM | |
| SCHEMBL1843566 | 0.66 | KEAP1 (0.49) | SLC9A3 | |
| SCHEMBL8308960 | 0.66 | IDH1 (0.46) | KDM4EHTR7 | |
| SCHEMBL4543332 | 0.66 | DDB1 (0.50) | MGLL | |
| SCHEMBL3361698 | 0.66 | MGLL (0.43) | MGLLKDM4ENOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2367820-B1 | NOVEL ANTIMICROBIAL AGENTS | PANACEA BIOTEC LTD (IN) | 2016-09-21 | — | — | EP | disclosed |
| US-8841306-B2 | Antimicrobials | PANACEA BIOTEC LTD. (IN) | 2014-09-23 | — | — | US | disclosed |
| US-20110245258-A1 | NOVEL ANTIMICROBIALS | PANACEA BIOTEC LTD. (IN) | 2011-10-06 | — | — | US | disclosed |
| EP-2367820-A2 | Novel antimicrobials | Panacea Biotec Limited (IN) | 2011-09-28 | — | — | EP | disclosed |
| WO-2010058423-A2 | NOVEL ANTIMICROBIALS | PANACEA BIOTEC LTD. (IN) | 2010-05-27 | — | — | WO | disclosed |
| WO-2009116090-A2 | NOVEL ANTIMICROBIALS | PANACEA BIOTEC LIMITED (IN) | 2009-09-24 | — | — | WO | disclosed |
| WO-2008090570-A1 | NOVEL ANTIMICROBIALS | PANACEA BIOTEC LTD (IN) | 2008-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245258-A1 | NOVEL ANTIMICROBIALS | ECI1, XDH, CYP3A4 | PRKAG1 3814/4885PRKAA1 1387/4885PRKAB1 3398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.